Get started
Author

Claudia Kiewitz

Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440
2002 · K. E. Nelson, C. Weinel, et al. · Environmental Microbiology · 1,369
Sequence Diversity of Pseudomonas aeruginosa : Impact on Population Structure and Genome Evolution
2000 · Claudia Kiewitz, Burkhard Tümmler · Journal of Bacteriology · 171
Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections
1999 · Burkhard Tümmler, Claudia Kiewitz · Molecular Medicine Today · 127
Monitoring genome evolution ex vivo: reversible chromosomal integration of a 106 kb plasmid at two tRNALys gene loci in sequential Pseudomonas aeruginosa airway isolates The GenBank accession numbers for the sequences reported in this paper are AF285416–AF285426.
2000 · Claudia Kiewitz, Karen Larbig, et al. · Microbiology · 61
Comparative Genomics of Pseudomonas aeruginosa PAO1 and Pseudomonas putida KT2440: Orthologs, Codon Usage, Repetitive Extragenic Palindromic Elements, and Oligonucleotide Motif Signatures
2002 · Christian Weinel, David W. Ussery, et al. · Genome Letters · 16
Pathogenicity Islands and PAI-Like Structures in Pseudomonas Species
2002 · K. Larbig, C. Kiewitz, et al. · Current topics in microbiology and immunology · 14
Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440
2003 · K. E. Nelson, C. Weinel, et al. · Environmental Microbiology · 12
First-line Bevacizumab-containing Therapy for HER2-negative Metastatic Breast Cancer: Final Results from a Prospective German Study.
2016 · Andreas Schneeweiss, Frank Förster, et al. · PubMed · 10
Genome Codon Index of Pseudomonas aeruginosa: A Codon Index That Utilizes Whole Genome Sequence Data
2002 · Claudia Kiewitz, Christian Weinel, et al. · Genome Letters · 5
Similar Profile of Single Nucleotide Substitution Types in Bacteria and Human Genetic Disease
2002 · Claudia Kiewitz, Burkhard Tümmler · Genome Letters · 3
First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany
2024 · Theo Leitner, Cyrus Khandanpour, et al. · Frontiers in Hematology · 1
PDF
Abstract P4-13-26: Efficacy, safety, and treatment decision-making in the AVANTI German observational study of first-line bevacizumab (BEV)-containing therapy for locally advanced, recurrent, or metastatic breast cancer (aBC)
2016 · V Müller, A Jakob, et al. · Cancer Research · 1
2754 First interim analysis of OTILIA, a large German non-interventional study evaluating front-line bevacizumab (BEV)-containing therapy in patients with ovarian cancer (OC)
2015 · A. Mustea, G. Oskay-Oezcelik, et al. · European Journal of Cancer · 1
Preliminary results of efficacy and tolerability of first-line bevacizumab in combination with carboplatin/paclitaxel in patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer in clinical practice - a German cohort study.
2015 · Alexander Mustea, Sven Mahner, et al. · Journal of Clinical Oncology
The role of surgery in patients with primary metastatic breast cancer (PMBC) receiving monoclonal antibody treatment.
2014 · Jana Barinoff, Marcus Schmidt, et al. · Journal of Clinical Oncology
Differenz im Überleben zwischen der Mammakarzinompatientinnen mit der primären und sekundären Metastasierung nach Trastuzumab- oder Bevacizumab-haltiger Therapie.
2014 · J Barinoff, M Schmidt, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
COMPARE - Results of a randomised study to assess the renal safety and efficacy of ibandronate and zoledronate in multiple myeloma patients
2010 · Raoul Bergner, Hartmut Goldschmidt, et al. · Bone
Works count: 17
Citation count: 1,791
H-index: 8
I10-index: 8
Year
Topic
Type